Skip to content

STXS - Stereotaxis, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchS

Stereotaxis Inc

STXS · AMEX

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

S

STXSStereotaxis Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $3.59
52-wk low: $1.24
Prev close: $2.35
Mkt cap: $138.3M
Fwd P/E: 19.6x
Beta: 1.40

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$10.4M

AQ
AQR
Q2 2026 13F
$338K
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -74.2%
Forward P/E: 19.65
Market cap: $138M

Valuation

P/S4.60
P/B11.13

Quality

Operating margin-59.6%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: STXS
Exchange: AMEX
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
Market cap: $138.28M
Beta: 1.40

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

4.6x

P/B

11.1x

Profit margin

-74.2%

Op margin

-59.6%

ROE

-184.3%

$315K

position

TS

Two Sigma

Q4 2025 13F

$156K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for STXS

No recent insider trade
No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

What the street expects next

EPS expected

-$0.05

-$0.06 to -$0.04

Revenue expected

$11.0M

4 analysts

Last 30 days

0up1down

Analysts cutting estimates

ROE

-184.3%

ROA-25.4%

Growth

Beta1.40